Tuesday, 17 September 2019

Clinical Research News

  • Roche starts phase III trial of its eye drug

    Clinical Research |  News | By BioSpectrum Bureau  | 0 Comment | 17 Sep, 2014

    Singapore: Swiss drugmaker Roche announced that it has started late-stage trials of its experimental drug, Lampalizumab. The drug is to be used in the treatment of Geographic Atrophy (GA),...Read more

  • PharmaNet/i3 wins award for oncology research

    Clinical Research |  News | By BioSpectrum Bureau  | 0 Comment | 08 Jun, 2012

    Singapore: PharmaNet/i3, inVentiv Health's clinical segment, and a leading provider of clinical development services to pharmaceutical, biotechnology, generic drug and medical device compan...Read more

  • Abuse of clinical trial laws need to be prevented

    Clinical Research |  Opinion | By BioSpectrum Bureau  | 0 Comment | 15 Oct, 2012

    Clinical trial is a process which involves testing of efficacy of drugs for the purpose of determination of safety, proper dosage range and side effects, prior to the drug being certified a...Read more

  • US state pays PRA $0.4 mn for creating jobs

    Clinical Research |  News | By BioSpectrum Bureau  | 0 Comment | 10 May, 2013

    Singapore: PRA, a leading clinical research organization, has received a $400,000 grant from the Kansas Bioscience Authority (KBA) to create 80 new jobs this year in Kansas, US. The gradua...Read more

  • Marken enters S. Korea

    Clinical Research |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore, June 8, 2012: Global clinical supply chain service provider, Marken has opened its first office in South Korea. The office will manage customer service operations and offer local...Read more

  • RedHill Biopharma announces dosing of first patient in the phase III study with RHB-104 for Crohn’s Disease

    Clinical Research |  News | 0 Comment | 22 Mar, 2017

    RedHill Biopharma Ltd., a specialty biopharmaceutical company primarily focused on the development and commercialization of late clinical-stage, proprietary, orally-administered, small mole...Read more

  • Minoryx Therapeutics completes phase 1 clinical trial for MIN-102

    Clinical Research |  News | 0 Comment | 22 Mar, 2017

    Minoryx Therapeutics, a drug development company specialized in the discovery of new drugs for orphan diseases, announced that it has successfully completed its phase 1 trial with MIN-102.M...Read more



Podcast

 

Survey Box

Is Pharma innovation getting inhibited in APAC?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls